Cite
Mansi ET, Johnson ES, Thorp ML, et al. Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021;30(12):1630-1634doi: 10.1002/pds.5361.
Mansi, E. T., Johnson, E. S., Thorp, M. L., Go, A. S., Lee, M. S., Shen, A. Y., Park, K. J., Budzynska, K., Markin, A., Sung, S. H., Thompson, J. H., Slaughter, M. T., Luong, T. Q., An, J., Reynolds, K., Roblin, D. W., Cassidy-Bushrow, A. E., Kuntz, J. L., Schlienger, R. G., Behr, S., & Smith, D. H. (2021). Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiology and drug safety, 30(12), 1630-1634. https://doi.org/10.1002/pds.5361
Mansi, Elizabeth T, et al. "Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy." Pharmacoepidemiology and drug safety vol. 30,12 (2021): 1630-1634. doi: https://doi.org/10.1002/pds.5361
Mansi ET, Johnson ES, Thorp ML, Go AS, Lee MS, Shen AY, Park KJ, Budzynska K, Markin A, Sung SH, Thompson JH, Slaughter MT, Luong TQ, An J, Reynolds K, Roblin DW, Cassidy-Bushrow AE, Kuntz JL, Schlienger RG, Behr S, Smith DH. Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1630-1634. doi: 10.1002/pds.5361. Epub 2021 Oct 01. PMID: 34558760.
Copy
Download .nbib